| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | parathyroid hormone receptor activity | 4.67e-05 | 2 | 137 | 2 | GO:0004991 | |
| GeneOntologyCellularComponent | spectrin | 2.25e-05 | 9 | 137 | 3 | GO:0008091 | |
| Domain | TRPM_tetra | 2.77e-09 | 4 | 137 | 4 | PF16519 | |
| Domain | TRPM_tetra | 2.77e-09 | 4 | 137 | 4 | IPR032415 | |
| Domain | Spectrin | 2.20e-05 | 23 | 137 | 4 | PF00435 | |
| Domain | ACTININ_2 | 2.20e-05 | 23 | 137 | 4 | PS00020 | |
| Domain | ACTININ_1 | 2.20e-05 | 23 | 137 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.20e-05 | 23 | 137 | 4 | IPR001589 | |
| Domain | PH_dom-spectrin-type | 3.14e-05 | 9 | 137 | 3 | IPR001605 | |
| Domain | - | DCAF1 KIF21B FBXW10B FBXW10 APAF1 NUP214 TEP1 TBL3 SEMA4G NBAS DCAF4 | 3.52e-05 | 333 | 137 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DCAF1 KIF21B FBXW10B FBXW10 APAF1 NUP214 TEP1 TBL3 SEMA4G NBAS DCAF4 | 3.72e-05 | 335 | 137 | 11 | IPR015943 |
| Domain | Spectrin_repeat | 5.71e-05 | 29 | 137 | 4 | IPR002017 | |
| Domain | SPEC | 8.49e-05 | 32 | 137 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 8.49e-05 | 32 | 137 | 4 | IPR018159 | |
| Domain | CD225/Dispanin_fam | 1.05e-04 | 13 | 137 | 3 | IPR007593 | |
| Domain | CD225 | 1.05e-04 | 13 | 137 | 3 | PF04505 | |
| Domain | CAC1F_C | 1.59e-04 | 3 | 137 | 2 | IPR031688 | |
| Domain | CAC1F_C | 1.59e-04 | 3 | 137 | 2 | PF16885 | |
| Domain | Ion_trans_dom | 1.95e-04 | 114 | 137 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.95e-04 | 114 | 137 | 6 | PF00520 | |
| Domain | WD_REPEATS_1 | 2.15e-04 | 278 | 137 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.20e-04 | 279 | 137 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.20e-04 | 279 | 137 | 9 | PS50294 | |
| Domain | Spectrin_bsu | 3.17e-04 | 4 | 137 | 2 | IPR016343 | |
| Domain | V_ATPase_I | 3.17e-04 | 4 | 137 | 2 | PF01496 | |
| Domain | VDCC_L_a1su | 3.17e-04 | 4 | 137 | 2 | IPR005446 | |
| Domain | V-type_ATPase_116kDa_su_euka | 3.17e-04 | 4 | 137 | 2 | IPR026028 | |
| Domain | V-ATPase_116kDa_su | 3.17e-04 | 4 | 137 | 2 | IPR002490 | |
| Domain | Quino_amine_DH_bsu | 5.37e-04 | 22 | 137 | 3 | IPR011044 | |
| Domain | Alpha_kinase | 7.86e-04 | 6 | 137 | 2 | PF02816 | |
| Domain | MHCK_EF2_kinase | 7.86e-04 | 6 | 137 | 2 | IPR004166 | |
| Domain | DUSP | 7.86e-04 | 6 | 137 | 2 | PF06337 | |
| Domain | DUSP | 7.86e-04 | 6 | 137 | 2 | SM00695 | |
| Domain | ALPHA_KINASE | 7.86e-04 | 6 | 137 | 2 | PS51158 | |
| Domain | Alpha_kinase | 7.86e-04 | 6 | 137 | 2 | SM00811 | |
| Domain | WD40 | 8.22e-04 | 268 | 137 | 8 | SM00320 | |
| Domain | WD40_repeat | 9.05e-04 | 272 | 137 | 8 | IPR001680 | |
| Domain | GPCR_2_secretin-like | 9.83e-04 | 60 | 137 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 9.83e-04 | 60 | 137 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.05e-03 | 61 | 137 | 4 | PS50261 | |
| Domain | DUSP | 1.09e-03 | 7 | 137 | 2 | PS51283 | |
| Domain | Ca_chan_IQ | 1.09e-03 | 7 | 137 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.09e-03 | 7 | 137 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.09e-03 | 7 | 137 | 2 | IPR014873 | |
| Domain | - | 1.09e-03 | 7 | 137 | 2 | 3.30.2230.10 | |
| Domain | GPHH | 1.09e-03 | 7 | 137 | 2 | PF16905 | |
| Domain | GPHH_dom | 1.09e-03 | 7 | 137 | 2 | IPR031649 | |
| Domain | Pept_C19_DUSP | 1.09e-03 | 7 | 137 | 2 | IPR006615 | |
| Domain | CH | 1.33e-03 | 65 | 137 | 4 | SM00033 | |
| Domain | WD40_repeat_CS | 1.33e-03 | 164 | 137 | 6 | IPR019775 | |
| Domain | WD40_repeat_dom | 1.58e-03 | 297 | 137 | 8 | IPR017986 | |
| Domain | CH | 1.75e-03 | 70 | 137 | 4 | PF00307 | |
| Domain | - | 1.84e-03 | 71 | 137 | 4 | 1.10.418.10 | |
| Domain | Prefoldin | 1.94e-03 | 72 | 137 | 4 | IPR009053 | |
| Domain | CH | 2.04e-03 | 73 | 137 | 4 | PS50021 | |
| Domain | CH-domain | 2.25e-03 | 75 | 137 | 4 | IPR001715 | |
| Domain | VDCCAlpha1 | 2.31e-03 | 10 | 137 | 2 | IPR002077 | |
| Domain | - | 2.40e-03 | 391 | 137 | 9 | 2.30.29.30 | |
| Domain | Frizzled | 2.81e-03 | 11 | 137 | 2 | IPR000539 | |
| Domain | Frizzled | 2.81e-03 | 11 | 137 | 2 | PF01534 | |
| Domain | ZnF_UBP | 2.81e-03 | 11 | 137 | 2 | SM00290 | |
| Domain | Frizzled | 2.81e-03 | 11 | 137 | 2 | SM01330 | |
| Domain | WD40 | 3.04e-03 | 259 | 137 | 7 | PF00400 | |
| Domain | Ran_BP1 | 3.36e-03 | 12 | 137 | 2 | PF00638 | |
| Domain | WWE | 3.36e-03 | 12 | 137 | 2 | PF02825 | |
| Domain | RANBD1 | 3.36e-03 | 12 | 137 | 2 | PS50196 | |
| Domain | WWE-dom | 3.36e-03 | 12 | 137 | 2 | IPR004170 | |
| Domain | WWE | 3.36e-03 | 12 | 137 | 2 | PS50918 | |
| Domain | G-protein_beta_WD-40_rep | 3.54e-03 | 85 | 137 | 4 | IPR020472 | |
| Domain | Acyl-CoA_dh_1 | 3.95e-03 | 13 | 137 | 2 | PF00441 | |
| Domain | RanBD | 3.95e-03 | 13 | 137 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 3.95e-03 | 13 | 137 | 2 | IPR000156 | |
| Domain | PH_dom-like | 4.23e-03 | 426 | 137 | 9 | IPR011993 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.59e-03 | 14 | 137 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.59e-03 | 14 | 137 | 2 | IPR024743 | |
| Domain | Znf_UBP | 4.59e-03 | 14 | 137 | 2 | IPR001607 | |
| Domain | zf-UBP | 4.59e-03 | 14 | 137 | 2 | PF02148 | |
| Domain | TUDOR | 4.59e-03 | 14 | 137 | 2 | PF00567 | |
| Domain | MT | 4.59e-03 | 14 | 137 | 2 | PF12777 | |
| Domain | AAA_8 | 4.59e-03 | 14 | 137 | 2 | PF12780 | |
| Domain | ZF_UBP | 4.59e-03 | 14 | 137 | 2 | PS50271 | |
| Domain | DHC_fam | 5.27e-03 | 15 | 137 | 2 | IPR026983 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 5.27e-03 | 15 | 137 | 2 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 5.27e-03 | 15 | 137 | 2 | IPR009100 | |
| Domain | Dynein_heavy | 5.27e-03 | 15 | 137 | 2 | PF03028 | |
| Domain | Acyl-CoA_dh_M | 5.27e-03 | 15 | 137 | 2 | PF02770 | |
| Domain | Dynein_heavy_dom | 5.27e-03 | 15 | 137 | 2 | IPR004273 | |
| Domain | AcylCo_DH/oxidase_C | 5.99e-03 | 16 | 137 | 2 | IPR009075 | |
| Domain | Frizzled/SFRP | 5.99e-03 | 16 | 137 | 2 | IPR015526 | |
| Domain | PH | 6.91e-03 | 229 | 137 | 6 | PF00169 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.77e-05 | 10 | 106 | 3 | MM15112 | |
| Pathway | REACTOME_TRP_CHANNELS | 5.38e-05 | 28 | 106 | 4 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 5.38e-05 | 28 | 106 | 4 | M27241 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 6.53e-05 | 11 | 106 | 3 | M22033 | |
| Pubmed | 5.03e-08 | 50 | 139 | 6 | 26275350 | ||
| Pubmed | Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction. | 6.25e-08 | 3 | 139 | 3 | 27640936 | |
| Pubmed | IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. | 6.25e-08 | 3 | 139 | 3 | 26387945 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 21177806 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 25422070 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 28511927 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 30365177 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 34933450 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 21253575 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 34319159 | ||
| Pubmed | IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. | 6.25e-08 | 3 | 139 | 3 | 34321474 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 27219333 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 31792954 | ||
| Pubmed | IFITMs restrict the replication of multiple pathogenic viruses. | 6.25e-08 | 3 | 139 | 3 | 24076421 | |
| Pubmed | IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. | 6.25e-08 | 3 | 139 | 3 | 23720721 | |
| Pubmed | IFITM proteins restrict antibody-dependent enhancement of dengue virus infection. | 6.25e-08 | 3 | 139 | 3 | 22479637 | |
| Pubmed | The C-terminal sequence of IFITM1 regulates its anti-HIV-1 activity. | 6.25e-08 | 3 | 139 | 3 | 25738301 | |
| Pubmed | Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins. | 6.25e-08 | 3 | 139 | 3 | 25463599 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 30087232 | ||
| Pubmed | IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread. | 6.25e-08 | 3 | 139 | 3 | 25464829 | |
| Pubmed | Lessons in self-defence: inhibition of virus entry by intrinsic immunity. | 6.25e-08 | 3 | 139 | 3 | 34646033 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 27440901 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 30266929 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 23358889 | ||
| Pubmed | Interferon-induced transmembrane proteins inhibit cell fusion mediated by trophoblast syncytins. | 6.25e-08 | 3 | 139 | 3 | 31735710 | |
| Pubmed | Opposing activities of IFITM proteins in SARS-CoV-2 infection. | 6.25e-08 | 3 | 139 | 3 | 33270927 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 25552713 | ||
| Pubmed | Dynamic expression of the TRPM subgroup of ion channels in developing mouse sensory neurons. | 1.18e-07 | 12 | 139 | 4 | 19850157 | |
| Pubmed | Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. | 2.49e-07 | 4 | 139 | 3 | 23376165 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 16395393 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 26354436 | ||
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 14516695 | ||
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 12659663 | ||
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 20064371 | ||
| Pubmed | 2.16e-06 | 7 | 139 | 3 | 18505827 | ||
| Pubmed | MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors. | 2.16e-06 | 7 | 139 | 3 | 23166351 | |
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 2.44e-06 | 24 | 139 | 4 | 33884443 | |
| Pubmed | 2.90e-06 | 25 | 139 | 4 | 16382100 | ||
| Pubmed | 3.99e-06 | 27 | 139 | 4 | 16460286 | ||
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 28880886 | ||
| Pubmed | 9.14e-06 | 33 | 139 | 4 | 19834762 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28356532 | ||
| Pubmed | IFITM3 affects the level of antibody response after influenza vaccination. | 1.59e-05 | 2 | 139 | 2 | 32321380 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22340213 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23977033 | ||
| Pubmed | Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. | 1.59e-05 | 2 | 139 | 2 | 16636202 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 30684640 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15254899 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26445298 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29356071 | ||
| Pubmed | Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice. | 1.59e-05 | 2 | 139 | 2 | 36880581 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 30416070 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25265877 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20814572 | ||
| Pubmed | IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization. | 1.59e-05 | 2 | 139 | 2 | 33882122 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24858416 | ||
| Pubmed | PTH-receptors regulate norepinephrine release in human heart and kidney. | 1.59e-05 | 2 | 139 | 2 | 21756942 | |
| Pubmed | IFITM3 regulates fibrinogen endocytosis and platelet reactivity in nonviral sepsis. | 1.59e-05 | 2 | 139 | 2 | 36194487 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 14688793 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22896038 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22969429 | ||
| Pubmed | Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. | 1.59e-05 | 2 | 139 | 2 | 24268777 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22511783 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19149903 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18365021 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 14976260 | ||
| Pubmed | Distinct Roles for APPL1 and APPL2 in Regulating Toll-like Receptor 4 Signaling in Macrophages. | 1.59e-05 | 2 | 139 | 2 | 27219021 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21602712 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18539702 | ||
| Pubmed | IFITM3 restricts the morbidity and mortality associated with influenza. | 1.59e-05 | 2 | 139 | 2 | 22446628 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25692682 | ||
| Pubmed | The TRPM6 kinase domain determines the Mg·ATP sensitivity of TRPM7/M6 heteromeric ion channels. | 1.59e-05 | 2 | 139 | 2 | 24385424 | |
| Pubmed | Listeria exploits IFITM3 to suppress antibacterial activity in phagocytes. | 1.59e-05 | 2 | 139 | 2 | 34404769 | |
| Pubmed | Deubiquitinases USP20/33 promote the biogenesis of tail-anchored membrane proteins. | 1.59e-05 | 2 | 139 | 2 | 33792613 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31451661 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21278253 | ||
| Pubmed | The channel kinases TRPM6 and TRPM7 are functionally nonredundant. | 1.59e-05 | 2 | 139 | 2 | 16150690 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28821869 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35708622 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18301276 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18675813 | ||
| Pubmed | Interferon-induced transmembrane protein 3 is a type II transmembrane protein. | 1.59e-05 | 2 | 139 | 2 | 24067232 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28220887 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29712757 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 37162420 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24163134 | ||
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 1.59e-05 | 2 | 139 | 2 | 31400758 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27268505 | ||
| Pubmed | Cloning of IP15, a pancreatitis-induced gene whose expression inhibits cell growth. | 1.59e-05 | 2 | 139 | 2 | 15184081 | |
| Pubmed | Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice. | 1.59e-05 | 2 | 139 | 2 | 23382131 | |
| Pubmed | Differential regulation of interferon-induced mRNAs and c-myc mRNA by alpha- and gamma-interferons. | 1.59e-05 | 2 | 139 | 2 | 3935435 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18192217 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 37450367 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 36989111 | ||
| Pubmed | Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin. | 1.59e-05 | 2 | 139 | 2 | 26563869 | |
| Pubmed | Interferon-induced Transmembrane Protein 3 Prevents Acute Influenza Pathogenesis in Mice. | 1.59e-05 | 2 | 139 | 2 | 32553073 | |
| Pubmed | [Neurodevelopmental impairment following neonatal immune challenge in mice]. | 1.59e-05 | 2 | 139 | 2 | 24212590 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26179995 | ||
| Pubmed | The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis. | 1.59e-05 | 2 | 139 | 2 | 30951861 | |
| Pubmed | Essential role for TRPM6 in epithelial magnesium transport and body magnesium homeostasis. | 1.59e-05 | 2 | 139 | 2 | 16075242 | |
| GeneFamily | EF-hand domain containing|Spectrins | 6.00e-06 | 7 | 102 | 3 | 1113 | |
| GeneFamily | Transient receptor potential cation channels | 1.76e-05 | 28 | 102 | 4 | 249 | |
| GeneFamily | Parathyroid hormone receptors | 3.15e-05 | 2 | 102 | 2 | 270 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 7.89e-05 | 78 | 102 | 5 | 262 | |
| GeneFamily | WD repeat domain containing | 7.10e-04 | 262 | 102 | 7 | 362 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 1.68e-03 | 11 | 102 | 2 | 559 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.68e-03 | 11 | 102 | 2 | 286 | |
| GeneFamily | Dyneins, axonemal | 4.06e-03 | 17 | 102 | 2 | 536 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 4.06e-03 | 17 | 102 | 2 | 1291 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 4.55e-03 | 18 | 102 | 2 | 498 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.24e-03 | 206 | 102 | 5 | 682 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.95e-03 | 394 | 102 | 7 | 471 | |
| GeneFamily | V-type ATPases | 7.38e-03 | 23 | 102 | 2 | 415 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-09 | 184 | 139 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-09 | 184 | 139 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-09 | 184 | 139 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.27e-07 | 200 | 139 | 8 | 326cae37cacd94b423a6ac8873ea56c5abaf0a0b | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 172 | 139 | 7 | 4fe5b91e4871bc6c5be57eb5b8bb04815b2fb80d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-06 | 194 | 139 | 7 | 8ac0b63c7a89e5ff78bbdd8dd1960aa2422a85f7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Mesenchymal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-06 | 194 | 139 | 7 | 4bafe26573cb2ff966f4a688c5769da598eea415 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 196 | 139 | 7 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 196 | 139 | 7 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.90e-06 | 197 | 139 | 7 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 161 | 139 | 6 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 161 | 139 | 6 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 161 | 139 | 6 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-05 | 173 | 139 | 6 | b57d14e2c2368304cb903562d06ce8228f53857c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 176 | 139 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 176 | 139 | 6 | c4d9166e5bbb7ca544107db14e4374289f5de6bd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 176 | 139 | 6 | d58ef51002ea50b3037636038214bbb7454cb503 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.98e-05 | 177 | 139 | 6 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | Severe-Myeloid-Neutrophil|Severe / Condition, Lineage, Cell class and cell subclass | 2.05e-05 | 178 | 139 | 6 | 454313efe59d71e7327b9758efabf2d893e4a8fd | |
| ToppCell | Severe-Myeloid-Neutrophil-|Severe / Condition, Lineage, Cell class and cell subclass | 2.05e-05 | 178 | 139 | 6 | 8618ae891d62bf70fe860ff7bb2d31868961aa13 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 178 | 139 | 6 | e2363810d77b6b245394a666eb51bacd345c43f7 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.25e-05 | 181 | 139 | 6 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-05 | 183 | 139 | 6 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.47e-05 | 184 | 139 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 184 | 139 | 6 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-05 | 186 | 139 | 6 | 9579180db2a0bf3f043b4d169f9a08cdc45b459a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-05 | 187 | 139 | 6 | 698ae9eefa8ba97fea8ea61e4e868edd194de03b | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-05 | 187 | 139 | 6 | ed8816433d1086a634892502898255b487a2d4a7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-05 | 187 | 139 | 6 | d8b09398400a178b03e641af1476c4dac0c6e82a | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 188 | 139 | 6 | 524a12f433c7b6f33fad36c0716afa06cd3235e9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 188 | 139 | 6 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 3.04e-05 | 191 | 139 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 3.13e-05 | 192 | 139 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.22e-05 | 193 | 139 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.42e-05 | 195 | 139 | 6 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-05 | 195 | 139 | 6 | 590c0dc0db4dc62879645ed7f61292ff97d2c7d5 | |
| ToppCell | distal-Endothelial-Lymphatic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.52e-05 | 196 | 139 | 6 | b0f23dc802a2c2a56a08d398a464ea78b58ade4c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | 8437c33e2c4a10a1b95343431e48d5e820b1f742 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-05 | 197 | 139 | 6 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.62e-05 | 197 | 139 | 6 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-05 | 197 | 139 | 6 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | a6a64581699cfcb9607b288976fa3b09648725b7 | |
| ToppCell | distal-1-Endothelial-Lymphatic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.72e-05 | 198 | 139 | 6 | b6fea363463c8dd7e6780c085ece4900266a6286 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-05 | 198 | 139 | 6 | 882710bd6215e299257dd3df234292db9a2823ba | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.72e-05 | 198 | 139 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 3.72e-05 | 198 | 139 | 6 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | distal-1-Endothelial-Vein|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.72e-05 | 198 | 139 | 6 | eee6cb4fe0e1caf460869d5a0a57c9d259573f10 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.72e-05 | 198 | 139 | 6 | 58508a8df2714d769f137794c29441a7bd38b350 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.83e-05 | 199 | 139 | 6 | 5f67ea58512856cbdcef759088a5869720a947a8 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-05 | 199 | 139 | 6 | 6cfe5a3d0ad530411ebc11decb4ab4c529e018d5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.83e-05 | 199 | 139 | 6 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.83e-05 | 199 | 139 | 6 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-BMP_responsible_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | 8433f4d3e26f6706bc7f06597d10b89221ce6437 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | fe15fb050852c187f6f17fb4f6172e69fe7d74a4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial-Proteoglycan-expressing_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | d0a4c3bf9c5211defb4c1d0b6653833cccbd29ee | |
| ToppCell | mild-NK_CD56bright|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.93e-05 | 200 | 139 | 6 | 6de701985a0b92a7dece1b0e4a76e13756ccc0dd | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-NK_CD56bright|Multiple_Sclerosis / Disease, condition lineage and cell class | 3.93e-05 | 200 | 139 | 6 | d06bea5b4af9559a517e769a373b873cd7bdcb48 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-05 | 135 | 139 | 5 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.93e-05 | 144 | 139 | 5 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | Lymphoid-Lymphoid-NK_cells|Lymphoid / shred on cell class and cell subclass (v4) | 1.02e-04 | 148 | 139 | 5 | d51a4b654a88d58dcdf29c2bc362c0cc1c40723a | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Plin3_(Plin3)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 80 | 139 | 4 | 0d5770c81a223148e57d625ac2c2ae69ab55b36e | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Plin3_(Plin3)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 80 | 139 | 4 | 413796630e7aeff7c68a69dd2d9b8cd8f56163b4 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.22e-04 | 154 | 139 | 5 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 139 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.46e-04 | 160 | 139 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 139 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-NK_CD56bright|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.60e-04 | 163 | 139 | 5 | 82c4b25f05bd404fdee9aa90f23efd6dffc04e7b | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.64e-04 | 164 | 139 | 5 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-04 | 165 | 139 | 5 | 66f0364098d82629aa2ec1dfe0c5ad23de7c2c12 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.79e-04 | 167 | 139 | 5 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 167 | 139 | 5 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 168 | 139 | 5 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 168 | 139 | 5 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-04 | 168 | 139 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 168 | 139 | 5 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-04 | 169 | 139 | 5 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.89e-04 | 169 | 139 | 5 | f68195510b91e287fe1507455ca067ece77a3897 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.89e-04 | 91 | 139 | 4 | 3f56358ff0dacdf6b8fc22cea64082231bceb851 | |
| ToppCell | droplet-Fat-Bat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 170 | 139 | 5 | c720d81bc29a8fd1f1249c6af408471d561f1d5d | |
| ToppCell | droplet-Fat-Bat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 170 | 139 | 5 | c4ecdfc2b4710da0a5fbb20e9df02536023badb1 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-04 | 171 | 139 | 5 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 172 | 139 | 5 | c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 172 | 139 | 5 | 7c085c02b59e24e2a2cd393b5e692f9fb19257fe | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-04 | 173 | 139 | 5 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 173 | 139 | 5 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-04 | 173 | 139 | 5 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-04 | 173 | 139 | 5 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-04 | 173 | 139 | 5 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-04 | 173 | 139 | 5 | 30fa8c14c8a1f546f380132c0c28a61e6a2f9fc4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 173 | 139 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-04 | 173 | 139 | 5 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-04 | 173 | 139 | 5 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 174 | 139 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 175 | 139 | 5 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 175 | 139 | 5 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.34e-04 | 177 | 139 | 5 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-04 | 177 | 139 | 5 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 177 | 139 | 5 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-04 | 177 | 139 | 5 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 177 | 139 | 5 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| Drug | mono-(2-ethylhexyl)phthalate | KIF21B ABCA4 TDRD9 SPTBN2 SREBF2 DNAH14 SEMA4G SPTBN4 SPTBN5 FAT1 DMD MYO15A LY75 FER1L5 RSPH9 ACOXL | 2.52e-06 | 658 | 138 | 16 | ctd:C016599 |
| Disease | MASA syndrome (implicated_via_orthology) | 3.09e-06 | 7 | 133 | 3 | DOID:0060246 (implicated_via_orthology) | |
| Disease | alcohol and nicotine codependence | 2.48e-05 | 13 | 133 | 3 | EFO_0004776 | |
| Disease | Abnormality of refraction | ABCA4 TDRD9 GPR78 DLK1 DSCAML1 FRY THBS4 GNPDA2 RORB ECEL1 TRPM1 KPNA2 | 5.60e-05 | 673 | 133 | 12 | HP_0000539 |
| Disease | Malignant neoplasm of breast | ABCA4 MAN2C1 SREBF2 NUP214 ATP6AP1L DAP3 N4BP2 APPL1 FGD5 DMD ANAPC5 DNAH9 PCDH8 GPR45 DOP1A | 1.04e-04 | 1074 | 133 | 15 | C0006142 |
| Disease | Congenital stationary night blindness | 1.20e-04 | 4 | 133 | 2 | cv:C0339535 | |
| Disease | congenital stationary night blindness (is_implicated_in) | 1.20e-04 | 4 | 133 | 2 | DOID:0050534 (is_implicated_in) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.20e-04 | 4 | 133 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.20e-04 | 4 | 133 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | autosomal recessive osteopetrosis 1 (implicated_via_orthology) | 2.00e-04 | 5 | 133 | 2 | DOID:0110942 (implicated_via_orthology) | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 5.55e-04 | 8 | 133 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 5.73e-04 | 36 | 133 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | acoustic startle blink response measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0006875 | |
| Disease | aspartate aminotransferase measurement | KIF21B ABCA4 TRPM7 NUP214 TBC1D8 P2RY2 TRPM3 NOSTRIN MYO15A LY75 MTCH2 ACOXL | 8.23e-04 | 904 | 133 | 12 | EFO_0004736 |
| Disease | X-Linked Csnb | 1.29e-03 | 12 | 133 | 2 | C3711543 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.29e-03 | 12 | 133 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.29e-03 | 12 | 133 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.29e-03 | 12 | 133 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.29e-03 | 12 | 133 | 2 | C1848172 | |
| Disease | brain disease (is_implicated_in) | 1.29e-03 | 12 | 133 | 2 | DOID:936 (is_implicated_in) | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.29e-03 | 12 | 133 | 2 | C1850362 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.52e-03 | 13 | 133 | 2 | C4041558 | |
| Disease | age at menarche | 1.53e-03 | 594 | 133 | 9 | EFO_0004703 | |
| Disease | episodic memory | 1.68e-03 | 52 | 133 | 3 | EFO_0004333 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.04e-03 | 15 | 133 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | response to olanzapine | 2.04e-03 | 15 | 133 | 2 | GO_0097333 | |
| Disease | ankle brachial index | 2.32e-03 | 16 | 133 | 2 | EFO_0003912 | |
| Disease | Night blindness, congenital stationary | 2.62e-03 | 17 | 133 | 2 | C0339535 | |
| Disease | Age-related macular degeneration | 2.94e-03 | 18 | 133 | 2 | cv:C0242383 | |
| Disease | brain measurement, neuroimaging measurement | 3.56e-03 | 550 | 133 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | hip bone mineral density, fat body mass | 4.39e-03 | 22 | 133 | 2 | EFO_0005409, EFO_0007702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QYCVELWNTDSRSKV | 861 | O14727 | |
| YFTNRKVNSVCWASL | 221 | Q8WV16 | |
| WNLKNGDTLYTCALR | 171 | P26439 | |
| RYALCSLSQGTLQWI | 226 | P78363 | |
| DWQVCASYLKTARVN | 326 | Q13686 | |
| ANSTQWTKANYTLLL | 126 | Q5XX13 | |
| SSQLNVSSCYWKEIV | 291 | Q9UPC5 | |
| WSLNTYKCTRQIISE | 131 | P53367 | |
| CTDKANILYAWARNA | 126 | P19021 | |
| CWSLQEKYNSRAAAL | 96 | Q8N6T3 | |
| SQRWLNLYLSACKFL | 2291 | Q5JWR5 | |
| SCAVTWYNQEKLILF | 471 | Q4L235 | |
| ETLTTNYQWLCTRLN | 1241 | P11532 | |
| QFTCNLLYVSWRKDL | 101 | O14678 | |
| FLNKCETWVSNLRYN | 326 | P80370 | |
| RSEKQCRSKWLNYLN | 316 | Q9Y222 | |
| SWYCNRGLVSLSAKI | 176 | Q8TBH0 | |
| LKAYSTWENIRCLQD | 331 | Q9NUZ1 | |
| CKRQVSTWTKQYQAA | 176 | Q709F0 | |
| VCNNETISVSSYKIW | 921 | Q9UPM8 | |
| LSLWLCNSLAYLVNT | 191 | Q9Y6C9 | |
| CRAYWKTTLSAEQNA | 136 | Q8N0V3 | |
| NVQWRALSELAALCY | 306 | P49792 | |
| WVSECKAKQSYVRAL | 166 | P34130 | |
| QHCLSWLYVLGQKRS | 341 | Q9UJX4 | |
| ANSTQWTKANYTLLL | 126 | O95170 | |
| VKSNACYWAVLLLVF | 526 | O60840 | |
| TKWYQFSILARCTQD | 2771 | Q14517 | |
| LQLISIACNWKTYYA | 601 | Q9Y4B6 | |
| RNLEYLNLSWCDQIT | 156 | Q9UKC9 | |
| KYQSALVCALLWALS | 146 | P04201 | |
| CQLYSEWRKTNQKVR | 201 | Q9P0N8 | |
| QAYASTAKCLNIWAL | 96 | Q01629 | |
| VRKCIATDTSQYDLW | 51 | Q9NXD2 | |
| SSKQDSCQRGWRLLY | 3126 | Q9UKN7 | |
| RSVNSSLKQCRWAYP | 421 | Q9P2D0 | |
| AQAYASTAKCLNIWA | 96 | Q01628 | |
| WICTINNISKQIYLS | 366 | Q9UKG1 | |
| YSRQQISLFWKNLSV | 336 | Q99665 | |
| SWYLKALETCSINNQ | 511 | Q6UWM7 | |
| CWVLSVAQSKTVRYS | 21 | O95206 | |
| RTVWKYFVQLCSALE | 136 | Q8TDX7 | |
| WRASVYLNDSLNKCS | 21 | Q6ZNL6 | |
| FTASSDCRVKLWNYV | 1601 | O75037 | |
| SCSQLLWLLKKSNRY | 211 | Q6UXP7 | |
| VSIKDWIYRQLCETS | 571 | Q9H0H0 | |
| VSWTQALRTIVKNCY | 256 | Q16656 | |
| WLSTVNQYKIRDTFC | 1236 | Q9P265 | |
| TALSWKEAYVSCQNQ | 236 | O60449 | |
| SLQQLRLYKQTSLWS | 881 | P35658 | |
| ALKRVYTLLSSWNCL | 186 | P18054 | |
| SVAYARVAKKLWLCN | 256 | Q9NYM4 | |
| VNAQWGILSKCLTYS | 271 | Q96P69 | |
| KLSQLYCSLVWESTV | 936 | Q7Z6Z7 | |
| WRKSAVNVASIQNYL | 561 | A2RRP1 | |
| YIFLCRLKTWNASTT | 56 | P41231 | |
| AQNWCIKRRSQSIYL | 716 | O95672 | |
| STCVLWLSYLKSVFN | 306 | Q9Y5Y3 | |
| RDWLASSAITLNIYC | 371 | Q7Z2Q7 | |
| CLIISAVDYNLTWQR | 541 | Q96RW7 | |
| AIWNTKFCVYSLESQ | 206 | Q8NB91 | |
| LACGYLRNLTWTLSN | 221 | P52292 | |
| VLKTSSWNLDCRYVL | 1076 | Q460N5 | |
| LCQADKTWNAVLLRY | 171 | Q14376 | |
| TNSDQYIWVKRSLNC | 186 | Q9ULV1 | |
| SKTFQTWQSLCYRKI | 531 | O00144 | |
| SLSNMCIYWLRQRQA | 46 | A6NJW9 | |
| RNLILALWYTNCKEA | 311 | Q8NB78 | |
| TRYWNSLSNLVASLL | 631 | Q13936 | |
| CSYSNNKSELWVSLI | 361 | Q9Y6W3 | |
| AQAYASTTKCLNIWA | 96 | C9JQL5 | |
| LRNLTCIYSKNEKWL | 86 | A2RUU4 | |
| RNRYSSQWTLTKCQA | 1741 | Q8TD84 | |
| RNSKWTLQCLISGRY | 101 | Q9NQT6 | |
| AIIKSIISCYNKNSW | 146 | Q5T1N1 | |
| WICAINNISRQIYLT | 366 | Q8NEU8 | |
| LQSCQASTWRKKLYL | 2571 | Q0VDD8 | |
| LASEWAAKYICNRII | 11 | Q8TDQ7 | |
| RLDITKWSYSLCISN | 106 | Q9HBG7 | |
| ACSQAQQLEWVKSRY | 296 | Q9NTJ4 | |
| VCIRKNWNSSDYLHL | 386 | P38567 | |
| WCRTVSEKSQYNLSQ | 666 | Q9NYC9 | |
| YNNRKEATLSWLANC | 2786 | Q5TBA9 | |
| LLSEQWCLEKSVSYQ | 61 | Q8N815 | |
| SLEWNSCVVQTLKEY | 191 | P0DJD0 | |
| STRLKWENTLENCYQ | 196 | Q8IVI9 | |
| QAYASTAKCLNIWAL | 76 | P13164 | |
| CWKLQQESRYQTVRS | 341 | P21217 | |
| WVKNCRDLLQSSYNK | 161 | P51398 | |
| KDAELVAQWNYCTLS | 26 | Q9BY42 | |
| YFLCIITSTWNLRTQ | 241 | P59542 | |
| RKTLYSLNCTEWSLL | 71 | Q9H1X1 | |
| YFWCQLTRNIQGLKT | 786 | O60522 | |
| NYQSLRLSWASKTSC | 476 | Q8NDG6 | |
| ERTCVQSQKDYIWSL | 1791 | A0AVI2 | |
| LTKNSLYWLSTQKFC | 506 | Q53T94 | |
| LWKIASCNGSIYVFR | 466 | Q9NVX7 | |
| SCIEQLEKSWSQYLA | 666 | O00291 | |
| YATGINQLISRWQKC | 661 | Q53H47 | |
| YLSCSEKWYQARLQT | 121 | Q96P15 | |
| CYWITRRFVNQLNTK | 151 | Q9P0N9 | |
| ALLKSIWYKCSEAQT | 416 | Q9HBY0 | |
| EALLVWCQRKTASYT | 181 | Q9NRC6 | |
| WCQRKTASYTNVNIT | 186 | Q9NRC6 | |
| LQKRYTTSSCWWQRL | 216 | Q9H853 | |
| TNRYAWQKNVNLSLT | 161 | Q6P3X8 | |
| SSLSFNTRLKWFAIC | 26 | Q8WV19 | |
| FSQENIIWSNLKYRC | 926 | P35443 | |
| ILANSWRYSSAFCNK | 111 | Q13454 | |
| NQCGKTYRRLWTLTE | 631 | Q9HCZ1 | |
| TYELRNWSNSTCLKL | 696 | Q9BX84 | |
| TQWKTLEASAICRYD | 326 | Q9NTN9 | |
| VAKQLYWQRVNSKCL | 796 | Q99973 | |
| QLQTASVYCSWELTL | 306 | Q13129 | |
| KKAANRSWQNVYCVL | 2236 | O15020 | |
| NRTWANYSECVKFLT | 161 | Q03431 | |
| LSNVLSSWCQYEALK | 191 | Q8TB61 | |
| NQTLKDYLSWRQADC | 166 | Q9NWX6 | |
| KEALLRFCVTWNTNS | 711 | Q12788 | |
| KLLTYELKNWSNATC | 746 | Q9HCF6 | |
| LWVTQKSSCYFILQR | 16 | O95759 | |
| ACSLSWNVIRYSLQK | 616 | Q12772 | |
| YQSKSREALWQQCAI | 261 | Q92753 | |
| KSSNRSWVSLYCVLS | 2436 | Q9H254 | |
| ASYTWQFEACKSQIL | 366 | Q9NRE2 | |
| NKTWANYSDCLRFLQ | 116 | P49190 | |
| IASRLGSWKQYQCTQ | 256 | Q9BXA5 | |
| NLTVNLTTFRLWCYA | 71 | Q9Y2K6 | |
| RWQNSKRLLYGSLVC | 441 | Q9P2E3 | |
| YELKNWSNSTCLKLA | 701 | Q7Z4N2 | |
| CISNTASYLRLWALS | 731 | Q93050 | |
| GALSKRYWTLFSCQV | 56 | Q9H497 | |
| QTWYFLVNTLCLALS | 576 | Q5H8A4 | |
| VYCNRASIRIQWTKL | 61 | Q6BDS2 | |
| ILTNYNKLSIQSWFS | 46 | Q52LC2 | |
| LKTTTNFTWCYLLRQ | 1936 | P15822 | |
| YELKNWSNSTCLKLA | 711 | Q96QT4 | |
| NLTTLRVWCYACSKE | 106 | Q8TEY7 | |
| CISNTASYLRLWALS | 746 | Q9Y487 | |
| VYTNVCRYTNWIQKT | 226 | Q92876 | |
| WLQLRSTGNLSTYNC | 266 | Q93070 | |
| YERCNKDIIWATSLL | 1111 | Q86UW6 |